Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6248915 | Transplantation Proceedings | 2011 | 12 Pages |
Abstract
An 80% reduction of de novo CsA exposure in combination with SRL engendered improved renal function as well as better graft survival at 10 years compared with patients treated with full CsA exposures with or without SRL co-therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
J. Pliszczynski, B.D. Kahan,